Literature DB >> 3742150

The effects of long-term infusion of salbutamol, diltiazem and nifedipine on uterine contractions in the ovariectomized, post-partum rat.

M H Abel, M Hollingsworth.   

Abstract

The sensitivity of the uterus to the inhibition of contractions by salbutamol, diltiazem or nifedipine was assessed in the ovariectomized, post-partum rat by dose-response curves following bolus intravenous (i.v.) administration. These tests were performed before (day 1), immediately after a 20 h i.v. infusion of salbutamol, diltiazem, nifedipine or appropriate control infusate (day 2) and after a further 20 h infusion of saline (day 3). In a further group of animals sensitivity to nifedipine was assessed before and after a 20 h infusion of salbutamol. Uterine contractions were monitored throughout infusions. Infusion of salbutamol (2 micrograms kg-1 min-1) produced an initial marked inhibition of uterine contractions, an effect which was not maintained despite continued infusion. Contractions reappeared after 2 h of infusion and reached pre-infusion levels by 5 h. The dose-response curve to salbutamol on day 2 was shifted more than 100 fold to the right compared with that on day 1. Sensitivity of the uterus on day 3 did not differ from that on day 1. Nifedipine (25 micrograms kg-1 min-1) produced sustained inhibition of uterine contractions throughout the 20 h of infusion. Sensitivity of the uterus to nifedipine could not, therefore, be tested on day 2; sensitivity on day 3 did not differ from that on day 1. In addition, there was no change in sensitivity of the uterus to nifedipine after a 20 h infusion of salbutamol. 4 Diltiazem (200 Ig kg-' min-') produced a marked initial inhibition of uterine contractions, with a partial return of contractions during continued infusion in 7 out of 12 animals so that mean integral values reached 40% of those pre-infusion. The dose-response curve to diltiazem on day 2 showed a 25 fold shift to the right compared with that on day 1 in 4 out of 12 animals where the test could be performed. Sensitivity of the uterus on day 3 did not differ from that on day 1. 5 These findings suggest that marked but reversible tolerance to the inhibitory actions of salbutamol on uterine contractions occurs during long-term infusion. There was no evidence of tolerance to the uterine actions of nifedipine, but there was evidence of tolerance to diltiazem in some animals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742150      PMCID: PMC1916984          DOI: 10.1111/j.1476-5381.1986.tb10238.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Effects of isoprenaline on the time course of the cyclic AMP level in rat uterus.

Authors:  S R Johansson; R G Anderson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-05

Review 2.  Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase.

Authors:  T K Harden
Journal:  Pharmacol Rev       Date:  1983-03       Impact factor: 25.468

Review 3.  Current status of beta-adrenergic agonists in bronchial asthma.

Authors:  S P Galant
Journal:  Pediatr Clin North Am       Date:  1983-10       Impact factor: 3.278

4.  Development of tolerance to oral salbutamol in the third trimester of pregnancy: a study of circulatory and metabolic effects.

Authors:  J Wager; B B Fredholm; N O Lunell; B Persson
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

Review 5.  Inhibition of myometrial activity by calcium antagonists.

Authors:  A Forman; K E Andersson; U Ulmsten
Journal:  Semin Perinatol       Date:  1981-07       Impact factor: 3.300

6.  Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

Authors:  M Spedding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

7.  Mechanisms of beta-adrenergic desensitization in rat myometrium.

Authors:  S R Johansson; R G Andersson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-10

8.  Is the relaxing effect of beta-adrenergic agonists on the human myometrium only transitory?

Authors:  G Rydén; R G Andersson; G Berg
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1982

9.  Deactivation of the uterus during normal and premature labor by the calcium antagonist nicardipine.

Authors:  A I Csapo; C P Puri; S Tarro; M R Henzl
Journal:  Am J Obstet Gynecol       Date:  1982-03-01       Impact factor: 8.661

10.  Effects of beta-adrenergic agonists on rat uterine motility and cAMP level in vivo.

Authors:  S R Johansson; R G Andersson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1980-07
View more
  5 in total

Review 1.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

2.  Tolerance to cromakalim in the rat uterus in vivo.

Authors:  S J Downing; M Miller; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

3.  Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects.

Authors:  S J Downing; D Edwards; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

4.  Nifedipine kinetics in the rat and relationship between its serum concentrations and uterine and cardiovascular effects.

Authors:  S J Downing; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

5.  One way cross tolerance between cromakalim and salbutamol in the uterus of the rat in vivo.

Authors:  S J Downing; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.